Skip to main content
Clinical Trials/ITMCTR1900002506
ITMCTR1900002506
Recruiting
Phase 1

A Randomized, Double-blind and Controlled Clinical Trial for Baihu Jiaguizhi Decoction in the Treatment of Acute Gouty Arthritis

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Adult subjects with a diagnosis of gout and with TCM diagnosis of damp\-heat obstruction syndrome;
  • 2\. Male and female patients aged 18\-65 years with independent behavior ability;
  • 3\. Within 48 hours of acute attack, no other similar treatment was given within 14 days before the trial;
  • 4\. eGFR\>\=30ml/min/1\.73m2;
  • 5\. Patients must sign informed consent to enter clinical research.

Exclusion Criteria

  • 1\) Patients do not meet the above inclusion criteria;
  • 2\) Female patients during pregnancy or lactation;
  • 3\) Patients are allergic to drug allergy of this subject or individual hypersensitivity;
  • 4\) The level of ALT was higher than 2 times normal;
  • 5\) Patients with serious primary diseases such as heart, liver, kidney, brain, endocrine system,hematopoietic system or mental illness;
  • 6\) Patients with severe joint deformity or even labor loss ;
  • 7\) Patients received the same treatment within 2 weeks before the trial;
  • 8\) Patients have the poor compliance to difficult to complete the clinical observer.

Outcomes

Primary Outcomes

Not specified

Similar Trials